Amgen · 1 day ago
CD&A - Senior Director, US Forecasting, Rare Disease
Amgen is a biotechnology company dedicated to serving patients with serious illnesses. The Senior Director of US Forecasting for Rare Disease will lead a forecasting team and provide strategic guidance to drive commercial success for oncology assets, while collaborating with various stakeholders to enhance forecasting methodologies and processes.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Primary point of contact for senior Therapeutic Area leaders to ensure development of data/insight driven short term and long term US forecasts for various brands within Rare Disease business unit
Preparing and presenting portfolio level forecast updates to address specific questions
Facilitate consensus-building among senior partners to establish clear, transparent, and rigorous sales expectations for the portfolio assets by gaining their alignment and endorsement for forecast assumptions (inline indications as well as new near term launches)
Help leadership identify actionable strategies to maximize Commercial potential by identifying and prioritizing relevant risks & opportunities
Analyze competitors and market dynamics to inform forecasting models and strategic decisions
Develop an objective point of view of portfolio strategy by integrating insights across multiple products, functions and capability areas
Leverage communication and interpersonal skills to influence leadership on recommended course of action
Quantify uncertainty through the use of scenario planning and advanced simulation models (e.g. Monte Carlo analysis, statistical trending)
Use an in-depth understanding of diverse pharmaceutical data sources (eg. LAAD, National Audit Rx, Xponent, Epidemiology data sources etc) and their nuances to develop and implement enhanced forecasting approaches and methodologies
Create and deliver effective presentations that are transparent and articulate all key variables in the forecast, ensuring clarity and comprehensive understanding for collaborators involved in decision-making processes
Collaborate with the broader CD&A (Commercial Data & Analytics) organization to integrate comprehensive insights and analytics knowledge into the development and refinement of forecasts. This collaboration aims to enhance the depth and accuracy of forecasts by leveraging a broad spectrum of insights across the organization
Drive productivity and efficiency, streamlining forecasting processes where possible
Qualification
Required
Doctorate degree and 5 years of experience in biopharma/biotechnology/pharmaceutical
Master's degree and 9 years of experience in biopharma/biotechnology/pharmaceutical
Bachelor's degree and 11 years of experience in biopharma/biotechnology/pharmaceutical
At least 5 years experience directly managing people and/or leadership experience leading teams, projects, programs, or directing the allocation of resources
Preferred
Leadership experience in building and developing hard-working teams
Ability to quickly establish credibility with and influence SVP/VP level staff
Alignment of teams to standard processes and championing new innovative methodologies and tools
Eye for business that lends itself to understanding the context and dynamics of pharmaceutical markets for relevant disease areas
Partnership with business leaders to deliver high-quality predictions guiding strategic and tactical decision-making
Oral, written, and presentation skills to explain complex concepts and controversial findings clearly to a variety of audiences, including senior management
Benefits
A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions
Group medical, dental and vision coverage
Life and disability insurance
Flexible spending accounts
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans
Flexible work models where possible
Company
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
H1B Sponsorship
Amgen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (429)
2024 (485)
2023 (485)
2022 (540)
2021 (460)
2020 (444)
Funding
Current Stage
Public CompanyTotal Funding
$28.5B2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO
Leadership Team
Recent News
pharmaphorum
2026-01-14
2026-01-13
2026-01-13
Company data provided by crunchbase